1. A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing. Issue 11 (11th May 2020) Authors: Liao, Kai H.; Udata, Chandrasekhar; Yin, Donghua; Sewell, K. Lea; Kantaridis, Constantino; Alvarez, Daniel F.; Meng, Xu Journal: British journal of clinical pharmacology Issue: Volume 86:Issue 11(2020) Page Start: 2182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biosimilar biologic drugs: a new frontier in medical care. Issue 4 (19th May 2017) Authors: Geynisman, Daniel M.; De Velasco, Guillermo; Sewell, K. Lea; Jacobs, Ira Journal: Postgraduate medicine Issue: Volume 129:Issue 4(2017) Page Start: 460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biosimilars Have Arrived: Rituximab. (22nd March 2018) Authors: Greenwald, Maria; Tesser, John; Sewell, K. Lea Other Names: Malemud Charles J. Academic Editor. Journal: Arthritis Issue: Volume 2018(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P-075 Systematic Review of Evidence for Monoclonal Antibody Biosimilars for the Treatment of Inflammatory Bowel Disease. (February 2017) Authors: Petersel, Danielle; Cheung, Raymond; Sewell, K. Lea; Singh, Ena; Isakov, Leah; Jacobs, Ira Journal: Inflammatory bowel diseases Issue: Volume 23(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗